相关实验视频
Updated: Mar 17, 2026

One-channel Cell-attached Patch-clamp Recording
Published on: June 9, 2014
具有胺功能的六基诺林:具有通道阻断活性的有希望的支架
Ebru Koçak Aslan1, Kevin Lam2, Sun Huang3
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
新的六氨基胺 (HHQ) 显示出作为心血管和疼痛疾病的通道阻断剂的潜力,比传统的以为基础的药物提供更好的代谢稳定性.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 心血管研究研究心血管研究
背景情况:
- 六基诺林 (HHQ) 衍生物被认为具有多种药理学作用.
- 1,4-二皮里丁 (DHP) 是通道阻断剂的核心药物,对于控制心血管疾病和疼痛至关重要.
- 目前的DHP利用功能;探索生物异胺替代品是新疗法的关键.
研究的目的:
- 合成具有或胺功能的新型HHQ化合物 (EM1-EM15).
- 研究这些化合物对L型 (Cav1.2) 和T型 (Cav3.2) 通道的影响.
- 评估含胺HHQs作为下一代通道阻断剂的潜力.
主要方法:
- 新型HHQ和胺衍生物 (EM1-EM15) 的合成.
- 全细胞补丁电生理学评估通道阻断活性.
- 用于结合模式分析的分子对接和动力学模拟.
- 在实验室中使用小鼠显微体进行代谢稳定性测试.
主要成果:
- 含胺的HHQ在L型和T型通道上都表现出显著的阻断活性,尽管其效果不如类对应物那么强大.
- 确定EM4的 (R) - 反体是通道阻塞的主要贡献者.
- 分子模拟揭示了Cav1.2中的结合模式类似于阿姆洛迪平,并确定了Cav3.2.2中的结合部位.
- 与相比,胺衍生物表现出更高的代谢稳定性.
结论:
- 带有胺基组的六基诺林支架代表了开发新型通道阻断剂的有希望的途径.
- 这些化合物显示出治疗心血管疾病和疼痛的潜力,增强了代谢稳定性.
- (R) 异构体对于观察到的通道阻断活性至关重要.
更多相关视频
10:20Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
07:42Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
相关概念视频
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers